Ghent, Belgium

Marc George Logghe

This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marc George Logghe. Retrieved from https://idiyas.com/inventor/marc-george-logghe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Marc George Logghe

Introduction

Marc George Logghe is a notable inventor based in Ghent, Belgium. He has made significant contributions to the field of biotechnology, particularly in the identification of genes critical for growth and cell division. His work has implications for developing selective drug targets to treat associated infections.

Latest Patents

Marc George Logghe holds 1 patent that focuses on the identification of genes or functional fragments essential for growth and cell division. This patent also includes novel nucleic acid sequences that encode polypeptides critical for growth. Additionally, it contemplates methods for identifying anti-fungal compounds that inhibit fungal or yeast growth.

Career Highlights

Logghe is currently employed at Janssen Pharmaceutica NV, a leading pharmaceutical company. His work at Janssen has allowed him to contribute to innovative solutions in the healthcare sector. His research is pivotal in advancing treatments for infections caused by fungi and yeast.

Collaborations

Throughout his career, Marc has collaborated with esteemed colleagues such as Bart Jozef Maria Nelissen and Walter Herman Maria Louis Luyten. These collaborations have enriched his research and expanded the impact of his inventions.

Conclusion

Marc George Logghe's contributions to biotechnology and his innovative patent work highlight his role as a significant inventor in the field. His research continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…